310 related articles for article (PubMed ID: 8889563)
21. [Update of experience with prostatic cancer].
Nitecki S; Kuten A; Cohen Y
Harefuah; 1993 Mar; 124(5):261-5, 320, 319. PubMed ID: 8495915
[TBL] [Abstract][Full Text] [Related]
22. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
[TBL] [Abstract][Full Text] [Related]
23. [Present status and questions on early prostatic cancer (stage A, B)].
Oishi K; Arai Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
[TBL] [Abstract][Full Text] [Related]
24. [Hormonal treatment of carcinoma of the prostate].
Obata K; Kobayashi H; Murase T; Ohisi M
Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study of prostatic cancer].
Kudo K; Nagata M; Hayashi N; Imamura H; Iwamoto K; Kimura M; Matsubara M; Mimura H; Matsuyama K; Suwa J
Hinyokika Kiyo; 1989 Aug; 35(8):1339-45. PubMed ID: 2816599
[TBL] [Abstract][Full Text] [Related]
26. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study on prostatic cancer patients].
Yasumoto R; Asakawa M
Hinyokika Kiyo; 1989 Jan; 35(1):65-9. PubMed ID: 2729021
[TBL] [Abstract][Full Text] [Related]
28. [Clinical studies on the prognostic factors in prostate cancer].
Horii Y; Yoshida T; Hirai S; Yamauchi T
Hinyokika Kiyo; 1998 Oct; 44(10):701-5. PubMed ID: 9850833
[TBL] [Abstract][Full Text] [Related]
29. [Prostatic cancer between 50 and 60. A more than 20-year-long retrospective study. Apropos of 65 case reports].
Aubert J; Orget J; Bon D; Marroncle M
Acta Urol Belg; 1993 Dec; 61(4):5-12. PubMed ID: 7507634
[TBL] [Abstract][Full Text] [Related]
30. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
[TBL] [Abstract][Full Text] [Related]
31. [Natural disease course in untreated early prostatic carcinoma--the Orebro Study].
Johansson JE
Praxis (Bern 1994); 2001 Sep; 90(36):1507-14. PubMed ID: 11593906
[TBL] [Abstract][Full Text] [Related]
32. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
33. [Trends in patterns of care for prostatic cancer in Japan: statistics of 9 institutions for 5 years].
Akakura K; Isaka S; Fuse H; Akimoto S; Imai K; Yamanaka H; Akaza H; Niijima T; Moriyama N; Kawabe K
Hinyokika Kiyo; 1988 Jan; 34(1):123-9. PubMed ID: 3376793
[TBL] [Abstract][Full Text] [Related]
34. [A multimodal treatment of prostatic carcinoma and the 5-year survival rate].
Maruoka M; Miyauchi T; Nagayama T
Hinyokika Kiyo; 1989 Jan; 35(1):57-63. PubMed ID: 2729020
[TBL] [Abstract][Full Text] [Related]
35. [Adenocarcinoma of the prostate].
Dvorácek J
Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
[TBL] [Abstract][Full Text] [Related]
36. Five-year follow-up of prostate cancer in Siriraj Hospital.
Soontrapa S; Tantiwong A; Leewansangtong S; Bhanalaph T
J Med Assoc Thai; 2000 Mar; 83(3):236-42. PubMed ID: 10808677
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age].
Kanamaru H; Shirahase T; Isogawa Y; Moroi S; Okuno H; Kihara Y; Kuo JY; Taniguchi T; Arai Y
Hinyokika Kiyo; 1994 May; 40(5):387-92. PubMed ID: 8023761
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
[TBL] [Abstract][Full Text] [Related]
39. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
40. [Radiotherapy of localized prostatic carcinoma].
Gez E; Netzer-Horowitz Y; Waiman E; Rubinov R; Cohen Y; Kuten A
Harefuah; 1997 Dec; 133(12):593-6, 664. PubMed ID: 9451865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
